Last updated on March 2017

A Randomized, double-blind, parallel-group, 12-week, chronic-dosing, multi-center study to assess the efficacy and safety of PT010 compared to PT009 in subjects with moderate to very severe chronic obstructive pulmonary disease (COPD).


Brief description of study

A Randomized, double-blind, parallel-group, 12-week, chronic-dosing, multi-center study to assess the efficacy and safety of PT010 compared to PT009 in subjects with moderate to very severe chronic obstructive pulmonary disease (COPD).

Detailed Study Description

This study is comparing a fixed-dose Triple combination product to a fixed-dose dual combination product. The study is for a 12-week duration. We are also including an option for a 24-hour Holter Monitoring as a sub-study to the main study.

Clinical Study Identifier: TX147806

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.